Geoffrey Wayne Krissansen

Title: Geoffrey Wayne Krissansen: Innovator in Peptide Therapeutics

Introduction

Geoffrey Wayne Krissansen is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of peptide therapeutics, holding a total of 4 patents. His work focuses on innovative methods for treating inflammatory diseases and demyelinating conditions.

Latest Patents

Krissansen's latest patents include groundbreaking inventions such as "Peptides and methods for the treatment of inflammatory disease." This invention relates to isolated peptides that comprise at least the amino acid sequence YDRREY or a derivative thereof. It also includes nucleic acids encoding the peptides, pharmaceutical compositions, and methods for modulating β7 integrin function, which are crucial for treating inflammatory disorders. Another significant patent is "Treatment of demyelinating diseases," which outlines methods for preventing central nervous system cell damage in mammals due to conditions like multiple sclerosis. This method involves co-administering specific compounds and anti-inflammatory agents to effectively treat demyelinating diseases.

Career Highlights

Throughout his career, Krissansen has worked with reputable organizations, including Auckland Uniservices Limited and Human Genome Sciences, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of peptide therapeutics.

Collaborations

Some of his notable coworkers include Jian Ni and Craig A Rosen. Their collaborative efforts have contributed to the advancement of research in peptide-based treatments.

Conclusion

Geoffrey Wayne Krissansen is a distinguished inventor whose work in peptide therapeutics has the potential to transform treatment options for inflammatory and demyelinating diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.